This study investigates the antiviral efficacy of ThymoQuin®(standardized black seed oil with high thymoquinone content) against the Influenza A (H1N1) virus in MDCK cells. Two test items, NSQ (ThymoQuin standardized at 3% thymoquinone) and NSQL (a blend of ThymoQuin with added lycopene, phytoene, phytofluene, and beta-carotene), were evaluated. ThymoQuin oils are cold-pressed and full-spectrum, ensuring high bioavailability and stability, which is also aided by NSQL’s carotene mixture from tomato extract. Utilizing Tamiflu as a positive control, we compare the antiviral activity of NSQ and NSQL to determine their potential as alternative or complementary treatments for influenza infections. Our findings demonstrate that both NSQ and NSQL exhibit significant antiviral activity, comparable to Tamiflu, making them promising candidates for antiviral therapy.
Thymoquinone, Influenza A (H1N1), MDCK cells, antiviral activity, bioavailability, Tamiflu, Nigella sativa, cold-pressed oil, full-spectrum oil.